Screener
Eligibility screening
Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Dise…
1 US site in FL
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.